<p>Dual Role For A MEK Inhibitor As A Modulator Of Inflammation And Host Defense Mechanisms With Potential Therapeutic Application In COPD</p>

Adult Male 0301 basic medicine MAP Kinase Kinase 2 MAP Kinase Kinase 1 International Journal of Chronic Obstructive Pulmonary Disease transcriptomics Diseases of the respiratory system Pulmonary Disease, Chronic Obstructive Young Adult 03 medical and health sciences exacerbation p38 mapk Humans Cells, Cultured Original Research Aged Inflammation RC705-779 steroid Diphenylamine sputum Middle Aged infection 3. Good health Benzamides Female alveolar macrophage Signal Transduction
DOI: 10.2147/copd.s211619 Publication Date: 2019-11-25T18:14:27Z
ABSTRACT
Background: Unlike p38 mitogen-activated protein Kinases (MAPK) that has been extensively studied in the context of lung-associated pathologies COPD, role dual-specificity kinase (MEK1/2) or its downstream signaling molecule extracellular signal-regulated kinases 1/2 (ERK1/2) COPD is poorly understood. Objectives: The aim this study was to address whether MEK1/2 pathway activation linked and targeting can improve lung inflammation through decreased immune-mediated inflammatory responses without compromising bacterial clearance. Methods: Association investigated by immunohistochemistry using tissue biopsies from healthy individuals analysis sputum gene expression data patients. anti-inflammatory effect inhibition assessed on cytokine release lipopolysaccharide-stimulated alveolar macrophages. clearance Staphylococcus aureus killing assays with RAW 264.7 macrophage cell line human neutrophils. Results: We report here demonstrated increased pERK1/2 staining bronchial epithelium presence MEK signature samples Inhibition resulted a superior macrophages comparison inhibitor. Furthermore, led an increase neutrophils cells not observed Conclusion: Our demonstrate highlight dual function improving host defense whilst also controlling inflammation. Keywords: exacerbation, infection, macrophage, MAPK, steroid, transcriptomics,
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (13)